# China NMPA Drug Inspection - Guangdong Bidi Pharmaceutical Co., Ltd. - Alendronate sodium tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangdong-bidi-pharmaceutical-co-ltd/f4b8d7ba-b08f-4516-99f8-90defae7bea5/
Source feed: China

> China NMPA drug inspection for Guangdong Bidi Pharmaceutical Co., Ltd. published July 28, 2022. Drug: Alendronate sodium tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 1, 2022)
- Company Name: Guangdong Bidi Pharmaceutical Co., Ltd.
- Publication Date: 2022-07-28
- Drug Name: Alendronate sodium tablets
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/guangdong-bidi-pharmaceutical-co-ltd/9e579f82-a219-49c9-ba98-ac135c1c6832/